Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis

Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis

ObjectiveThis meta-analysis evaluated pembrolizumab monotherapy and combination therapy’s efficacy and safety in recurrent or advanced endometrial cancer (EC).MethodsWe utilized PubMed, Embase, Cochrane Library, and Web of Science databases to identify clinical trials that were used to search litera...

Full description

Saved in:

Bibliographic Details
Main Authors:	Biqiong Pan, Xiaojun Lai, Jiefang Lu, Xiaoyan Bao, Zengke Fan, Jie Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	pembrolizumab monotherapy endometrial cancer meta-analysis efficacy and safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1511301/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
by: Xue Zhang, et al.
Published: (2024-12-01)

Meta-analysis of Efficacy and Safety of Fire Acupuncture in Treatment of Ganglion Cyst
by: Yanan LIU, et al.
Published: (2019-08-01)

Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report
by: Gosselin-Rousselle Louise, et al.
Published: (2024-01-01)

Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis
by: Tianmin Huang, et al.
Published: (2025-01-01)

Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials
by: Nikolas Naleid, et al.
Published: (2025-01-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
by: Bujnak AC, et al.
Published: (2025-01-01)

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis
by: Wenkai Zhang, et al.
Published: (2025-01-01)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
by: Jieran Long, et al.
Published: (2024-09-01)

Meta-analysis of the clinicopathologic features of endometrial cancer molecular staging
by: Xiaoxia Yin, et al.
Published: (2025-01-01)

Different surgical methods of hysterectomy for the management of endometrial cancer: a systematic review and network meta-analysis
by: Yuquan Yuan, et al.
Published: (2025-01-01)

The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
by: Xiaolu Luo, et al.
Published: (2025-01-01)

Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
by: Stewart M, et al.
Published: (2025-02-01)

A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer
by: FENG Huizhi, LIU Jingmei, BU Xiaoqian
Published: (2024-11-01)

Unusual gingival presentation following treatment with pembrolizumab
by: Annu Singh, et al.
Published: (2024-03-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)

Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review
by: Abdulrahman Hesham, et al.
Published: (2024-09-01)

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease
by: Haohang Su, et al.
Published: (2025-01-01)

Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma
by: Ka Hey Agnes Fong, et al.
Published: (2025-02-01)

Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
by: Chien-Tzu Huang*, et al.
Published: (2023-07-01)

Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
by: Joshua Chadwick, et al.
Published: (2025-01-01)

Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data
by: Fabrizio Nelli, et al.
Published: (2025-01-01)

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system
by: Wenwang Lang, et al.
Published: (2025-01-01)

An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
by: Vinod K. Ramani, et al.
Published: (2025-01-01)

Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels
by: Fei Yang, et al.
Published: (2025-01-01)

Effectiveness and Safety of Using Standardized Treatment Protocols for Hypertension Compared to Usual Care: A Meta‐Analysis of Randomized Clinical Trials
by: Gautam Satheesh, et al.
Published: (2025-01-01)

Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion?
by: Musen Wang, et al.
Published: (2025-02-01)

Identifying factors for pembrolizumab eligibility in head and neck cancer
by: Satoru Miyamaru, et al.
Published: (2025-02-01)

Prevalence of occult endometrial carcinoma in patients with endometrial intraepithelial neoplasia who underwent hysterectomy
by: Waraphon Thongsang, et al.
Published: (2025-01-01)

Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
by: Zhuan’E. Yao, et al.
Published: (2025-01-01)

To do or not to do? – Endometrial biopsy in younger women with abnormal uterine bleeding
by: Sandra Lynn Jaya-Bodestyne, et al.
Published: (2025-03-01)

Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials
by: Wenting Cai, et al.
Published: (2025-01-01)

Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium
by: Benjamin T. Schleenvoigt, et al.
Published: (2025-04-01)

The efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopy
by: Weifeng Shan, et al.
Published: (2025-01-01)

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis
by: Bowen Dai, et al.
Published: (2025-01-01)

Comparing the efficacy of different methods in assessing cervical stromal invasion in endometrial carcinoma: a retrospective study of 2,020 patients
by: Ying Yang, et al.
Published: (2025-02-01)

The significance of the immunohistochemical method in diagnosing atypical endometrial polyps as manifestations of localized hyperplasia
by: O.V. Poslavska, et al.
Published: (2024-12-01)

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Ji Ren, et al.
Published: (2025-01-01)

Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature
by: Hiroshi Katoh, et al.
Published: (2024-11-01)

Low L3 skeletal muscle index and endometrial cancer: a statistic pooling analysis
by: Na Aru, et al.
Published: (2025-01-01)